Pharmacokinetic Modeling of an Induction Regimen for In Vivo Combined Testing of Novel Drugs against Pediatric Acute Lymphoblastic Leukemia Xenografts

• Barbara Szymanska ,

  Contributed equally to this work with: Barbara Szymanska, Urszula Wilczynska-Kalak

  Affiliation Children's Cancer Institute Australia for Medical Research, University of New South Wales, Sydney, Australia

  ⨯
• Urszula Wilczynska-Kalak ,

  Contributed equally to this work with: Barbara Szymanska, Urszula Wilczynska-Kalak

  Affiliation Children's Cancer Institute Australia for Medical Research, University of New South Wales, Sydney, Australia

  ⨯
• Min H. Kang,

  Affiliation Texas Tech University Health Sciences Center, Lubbock, Texas United States of America

  ⨯
• Natalia L. M. Liem,

  Affiliation Children's Cancer Institute Australia for Medical Research, University of New South Wales, Sydney, Australia

  ⨯
• Hernan Carol,

  Affiliation Children's Cancer Institute Australia for Medical Research, University of New South Wales, Sydney, Australia

  ⨯
• Ingrid Boehm,

  Affiliation Children's Cancer Institute Australia for Medical Research, University of New South Wales, Sydney, Australia

  ⨯
• Daniel Groepper,

  Affiliation Department of Pharmaceutical Sciences, St. Jude Children's Hospital, Memphis, Tennessee, United States of America

  ⨯
• C. Patrick Reynolds,

  Affiliation Texas Tech University Health Sciences Center, Lubbock, Texas United States of America

  ⨯
• Clinton F. Stewart,

  Affiliation Department of Pharmaceutical Sciences, St. Jude Children's Hospital, Memphis, Tennessee, United States of America

  ⨯
• Richard B. Lock

  * E-mail: rlock@ccia.unsw.edu.au

  Affiliation Children's Cancer Institute Australia for Medical Research, University of New South Wales, Sydney, Australia

  ⨯